Back

Clinical impact of Sarcopenia on long-term mortality in patients undergoing coronary bypass grafting

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification and treatment in patients undergoing CABG Comorbidities ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jinhwan Jo

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
The impact of type 2 diabetes on short term myocardial morphological, functional, and energetic recovery post coronary artery bypass surgery in patients with ischemic heart disease
Doctor S. Kotha (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Colchicine in patients with coronary disease undergoing coronary artery bypass surgery: a meta-analysis of randomized controlled trials
Doctor H. Kirov (Jena, DE)
Abstract Slides Video
Presentation thumbnail
The utility of angiography-derived fractional flow reserve in predicting graft occlusions prior to bypass surgery
Doctor M. Buske (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
A randomized controlled trial of an eight-week cardiac rehabilitation home verse hospital exercise programme for post coronary cardiac bypass patients
Doctor M. Takroni (Riyadh, SA)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification and treatment in patients undergoing CABG

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The association between sarcopenia and post-discharge outcomes in patients with heart failure: data from the SMILE HF registry
thumbnail
Congress Presentation
Prognostic value of sarcopenia defined by the Sarcopenia Definitions and Outcomes Consortium criteria in patients with heart failure
thumbnail
Congress Presentation
Prognostic impact of the interaction between sarcopenia and aortic stenosis phenotypes on clinical outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources